A 64-year-old male suffered from splenomegaly without lymphadenopathy. His WBC count on admission was 6.1xlO9/l with 55%abnormal lymphocytes. No monoclonal gammopathy was detected. Abnormal cells shown in films usually had relatively abundant cytoplasm with serrated edges. Under phase-contrast microscopy, the cells displayed short, needle-like processes. The immunophenotype of peripheral blood mononuclear cells were CD19+, CD20+, CDllc+, FMC7+, CD5+, CD10", CD25" and SIg+. The spleen histology showed a distinctive pattern of white pulp infiltration by abnormal lymphocytes with features of plasma cell differentiation. These findings were compatible with the features of splenic lymphoma with villous lymphocytes. (Internal Medicine 32: 472-475, 1993) 
Introduction
Hairy cell leukemia (HCL) is defined as a distinct clinicopathologic entity on the basis of several distinguishing features (1) , but similar findings are also observed in a certain nonHodgkin's lymphoma. Such a lymphoma has been described under a variety of names (2) (3) (4) (5) (6) (7) (8) . The disease is characterized by splenomegaly, inconspicuous adenopathy, frequent occurrence of a small amountof monoclonalparaprotein in the serum, and the presence of lymphocytes with cytoplasmic projections (villous lymphocytes) in the peripheral blood. Spriano et al (6) considered the disease as a distinct variant of an immunocytoma on the basis ofhistological and hematological examinations and named it, splenomegalic immunocytomawith circulating hairy cells. Melo et al (7, 8) FMC7MoAb(Sera-Lab, Crawley Down, U.K.) was evaluated using FITC-conjugated anti-mouse IgM antibodies (TAGO Inc. , Burlingame, CA, U.S.A.) by indirect immunofluorescence.
The abnormal lymphocytes reacted with anti-IgA,, CD19 and CD20. They expressed CD1 lc and FMC7, as do hairy cells in HCL, but they did not react with anti-CD25 MoAb. The double immunofluorescent staining with FITC-conjugated anti-CD5 and PE-conjugated anti-CD19 MoAbrevealed that 17% of the CD19positive cells expressed CD5antigen.
On April 10, a splenectomy was performed to relieve the patient's stomach fullness. The spleen histology showed a distinctive pattern of white pulp infiltration of abnormal lymphocytes (Fig. 4a) . The abnormal lymphocytes displayed morphological features of plasma cell differentiation. No blood lakes or pseudosinuses, as described in HCLcases (9), were seen. A diagnosis of SLVLwas made based on these stated results. The patient has progressed satisfactorily since the operation and, as of March 1993, he is doing quite well and seems free of any clinical problems (Fig. 5 ).
Discussion
Our patient had marked splenomegaly with the absence of lymphadenopathy. The circulating lymphocytes had relatively abundant cytoplasm with serrated edges on the blood film and they showed the phenotype of SIg+, CD19+, CD20+, CDl lc+, FMC7+as well. These clinical, cytological and immunophenotypical findings were very similar to those described for HCLcases ( 1 ) . Under phase-contrast microscopy, most abnormal lymphocytes displayed short, needle-like villi (Fig. 2a) . The morphological features of the surface villi, however, appeared to differ from the thin, membranouscytoplasmic projections (ruffles) seen in HCLcells (Fig. 2b) Although the abnormal cells expressed CD5antigen, they were found to have a low nuclear/cytoplasmic ratio and surface villi, unlike chronic lymphocytic leukemia (CLL) lymphocytes. The present patient is histologically differentiated from nonHodgkin's lymphoma in the leukemic phase, including intermediate lymphocytic lymphomaand follicular lymphoma. Although the present findings are fundamentally in accordance with the features described for SLVLby Melo et al, some differences were noted between the present results and theirs. For example the CD5antigen was positive in our case, but was negative in all the cases reported by Melo. The CD1lc antigen wasalso positive in the present case, but Bennet et al (1) reported that SLVLcells did not react to Leu-M5 (CDl lc). Melo described a high incidence of a monoclonal gammopathy and, although the presence of monoclonal-protein (M-protein)
is helpful in the differentiation ofHCL, it was not detected in the present case. Most pertinent to the present case is the data of Valensi et al (10) , whoreported that the monoclonal band was positive in only 2 of 8 cases, and that in 7 of these 8 cases, the CD5antigen and the CD1lc antigen were expressed in 3 and 5 cases, respectively. These findings suggest that SLVL is heterogenous in the expression of CD5, CD1lc, and also in the existence of monoclonal gammopathy. Melo et al stressed an uneven, often polar distribution of surface villi in the blood films as a characteristic feature of SLVLcells, which differs from the HCLcells. Such a difference in cellular outlines of the cells in the present patient and that of the HCLcells was not apparent on the blood films. In our experience, the shape of cellular outlines on blood films depends on the method of making smears and also on the examination areas of the film. Villous lymphocytes in the present patient were shown to have distinguishing morphological features under phase-contrast microscopy. This finding may be useful for the differential diagnosis of SLVL.However, more research on this point is necessary. Except for CD19 and CD20, the expression of CD5, CD10, CD1lc, CD25 and CD38 in SLVLvaries from case to case (1, 8, 10) , and a specific surface marker for SLVLhas not yet been discovered (1, 8, 10) . Perhaps a reliable marker for SLVLwill be reported at a later time. SLVLis a low grade non-Hodgkin's lymphoma, and it follows either a stable or a slowly progressive clinical course. Thus, reports that focus on the therapy of this disease are rare.
Recently, Mulligan and associates (1 1) reported on the natural history of 50 cases of SLVLas well as on their response to therapy; they reported a survival rate for all patients of 82%at 3 years and 78% at 5 years, and they recommend splenectomy as the first choice of treatment for SLVL. Although villous lymphocytes are still detected in the present patient ' s peripheral blood, his clinical status is good after undergoing splenectomy.
